NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial : The Lancet Neurology
Links shared publicly online about this topic.
- 2,049total visits
NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial : The Lancet Neurology
NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial. By -...
View full resource at thelancet.com
Tags: Neurology, Multiple Sclerosis, Multiple Sclerosis Medication, Avonex, Rebif, Depo-Medrol, Medrol, Solu-Medrol
Most Recently Shared on May 12, 2009 at 1:15 pm By:
[Lancet Neurology] [Articles] NORdic trial of oral Methylprednisolone as add-on therapy to Int.. http://tinyurl.com/qqnez5
Advertisement
